BNP PARIBAS FINANCIAL MARKETS - MEDGENICS INC ownership

MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 28 filers reported holding MEDGENICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of MEDGENICS INC
ValueSharesWeighting
Q3 2016$10,160,000
+93.3%
1,824
+92.6%
0.00%
Q2 2016$5,256,000
-78.7%
947
-76.9%
0.00%
Q4 2015$24,646,000
-5.6%
4,094
+22.7%
0.00%
Q3 2015$26,095,000
+204.1%
3,337
+138.4%
0.00%
Q2 2015$8,582,000
+258.6%
1,400
+354.5%
0.00%
Q2 2014$2,393,000
+19.2%
3080.0%0.00%
Q1 2014$2,008,000
+8.8%
3080.0%0.00%
Q4 2013$1,845,0003080.00%
Other shareholders
MEDGENICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,058,400$8,277,0004.07%
Belmont Global Advisors, Inc. 155,000$1,212,0002.06%
Broadfin Capital, LLC 1,545,306$12,084,0000.67%
CARL DOMINO INC 34,134$267,0000.21%
QVT Financial LP 267,608$2,093,0000.07%
WHITE PINE CAPITAL LLC 20,000$156,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 119,000$931,0000.02%
HYMAN CHARLES D 13,000$102,0000.02%
Kavar Capital Partners, LLC 1,500$11,0000.01%
Brick & Kyle, Associates 1,000$8,0000.01%
View complete list of MEDGENICS INC shareholders